Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stress Hydrocortisone for Pediatric Septic Shock
MOH_2025-03-17_013976Phase 3Not yet recruiting
- Sponsor
- אין
- Start
- Mar 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in septic shock comparing Standard care + placebo with Standard care + hydrocortisone (2 arms). Primary endpoint: Composite poor outcome. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
hydrocortisone sodium succinate
03
Conditions
septic shock
Beyond the preview
Go deeper on MOH_2025-03-17_013976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2025-03-17_013976.